Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065141 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Ana Silva und 7 weiteren Autor:innen. Beteiligte Einrichtung: Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pancreatic Neoplasms, Symporters. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Science and Technology (FCT), Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF), Norte Portugal Regional Operational Programme (NORTE 2020).
Abstract (Originalsprache)
Energy production by cancer is driven by accelerated glycolysis, independently of oxygen levels, which results in increased lactate production. Lactate is shuttled to and from cancer cells via monocarboxylate transporters (MCTs). MCT1 works both as an importer and an extruder of lactate, being widely studied in recent years and generally associated with a cancer aggressiveness phenotype. The aim of this systematic review was to assess the prognostic value of MCT1 immunoexpression in different malignancies. Study collection was performed by searching nine different databases (PubMed, EMBASE, ScienceDirect, Scopus, Cochrane Library, Web of Science, OVID, TRIP and PsycINFO), using the keywords “cancer”, “Monocarboxylate transporter 1”, “SLC16A1” and “prognosis”. Results showed that MCT1 is an indicator of poor prognosis and decreased survival for cancer patients in sixteen types of malignancies; associations between the transporter’s overexpression and larger tumour sizes, higher disease stage/grade and metastasis occurrence were also frequently observed. Yet, MCT1 overexpression correlated with better outcomes in colorectal cancer, pancreatic ductal adenocarcinoma and non-small cell lung cancer patients. These results support the applicability of MCT1 as a biomarker of prognosis, although larger cohorts would be necessary to validate the overall role of MCT1 as an outcome predictor.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Campus of Gualtar, 4710-057 Braga, Portugal.
- ICVS/3B's-PT Government Associate Laboratory, 4710-057 Braga, Portugal.
ORCID-Profile: Mónica Costa Cerqueira, Filipa Pinto-Ribeiro, Marta Freitas Costa, Fátima Baltazar, Julieta Afonso
Förderung
- Foundation for Science and Technology (FCT)
- Norte Portugal Regional Operational Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF)
- Norte Portugal Regional Operational Programme (NORTE 2020)
Zitieren
APA
Silva, A., Cerqueira, M. C., Rosa, B., Sobral, C., Pinto-Ribeiro, F., Costa, M. F., Baltazar, F., & Afonso, J. (2023). Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065141
Vancouver
Silva A, Cerqueira MC, Rosa B, Sobral C, Pinto-Ribeiro F, Costa MF, et al. Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065141
BibTeX
@article{Silva2023,
author = {Silva, Ana and Cerqueira, Mónica Costa and Rosa, Beatriz and Sobral, Catarina and Pinto-Ribeiro, Filipa and Costa, Marta Freitas and Baltazar, Fátima and Afonso, Julieta},
title = {Prognostic Value of Monocarboxylate Transporter 1 Overexpression in Cancer: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065141}
}
EUVIMED